SUBSCRIBE
SUBSCRIBE

Partner Therapeutics, Inc. (PTx)

NEWS
Business
Top 20 Life Science Startups to Watch in 2019
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
November 6, 2018
 · 
12 min read
 · 
Mark Terry
Roche Could Take a $500M Hit Over Patent Losses
Deals
Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi.
February 1, 2018
 · 
2 min read
 · 
Mark Terry
Amneal and Impax to Marry, Creating the 5th Larges
Business
Former Merrimack, Sanofi Execs Launch Boston Cancer Startup
Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx.
January 25, 2018
 · 
2 min read
 · 
Mark Terry
Load More
AWARDS
  • NextGen Class of 2019
JOBS
IN THE PRESS
Drug Development
Partner Therapeutics Initiates Patient Enrollment in Clinical Trial Evaluating Leukine® (rhuGM-CSF, sargramostim) in High-risk Non-hospitalized COVID-19 Patients (SCOPE)
April 29, 2021
 · 
7 min read
Genetown
Partner Therapeutics Announces Publication of Clinical Trial Results Showing Significant Benefit with Use of Leukine® (sargramostim) in Patients with Alzheimer’s Disease
March 24, 2021
 · 
9 min read
Business
Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma to Explore Potential Uses for FX06 in Biodefense Applications
March 3, 2021
 · 
4 min read
Genetown
SARPAC Clinical Trial of Leukine® (sargramostim, rhu GM-CSF) in Hospitalized COVID-19 Patients Meets Primary Endpoint of Significant Improvement in Lung Function
February 26, 2021
 · 
12 min read
Genetown
Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS)
February 18, 2021
 · 
13 min read
Business
Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical Officer
September 15, 2020
 · 
3 min read
Drug Development
Partner Therapeutics Announces Start of Phase 3 Portion of Clinical Study of Leukine® in Combination with Ipilumimab and Nivolumab in Front Line Treatment of Melanoma
September 11, 2020
 · 
5 min read
Drug Development
Partner Therapeutics Initiates Patient Enrollment in U.S. Clinical Trial Evaluating Leukine® (rhuGM-CSF, sargramostim) in COVID-19 Patients
August 25, 2020
 · 
12 min read
Genetown
Partner Therapeutics Announces $35 Million Contract with U.S. Department of Defense for Advanced Development and Emergency Use of Leukine® (rhuGM-CSF) for COVID-19 Acute Hypoxemic Respiratory Failure (AHRF)
August 4, 2020
 · 
13 min read
Drug Development
Partner Therapeutics Announces Initiation of Clinical Trial Evaluating Leukine® in T Cell Replete HLA-mismatched Haploidentical Stem Cell Transplant
June 11, 2020
 · 
4 min read
Load More